VanEck Biotech ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
BBH price
Table
| Date | BBH close |
|---|---|
| Oct 16, 2026 | $241.36 |
| Oct 19, 2026 | $241.14 |
| Oct 20, 2026 | $248.78 |
| Oct 21, 2026 | $250.46 |
| Oct 22, 2026 | $248.41 |
| Oct 23, 2026 | $246.57 |
| Oct 26, 2026 | $247.39 |
| Oct 27, 2026 | $249.80 |
| Oct 28, 2026 | $253.27 |
| Oct 29, 2026 | $256.90 |
| Oct 30, 2026 | $257.98 |
| Nov 2, 2026 | $254.50 |
| Nov 3, 2026 | $255.57 |
| Nov 4, 2026 | $261.63 |
| Nov 5, 2026 | $251.01 |
| Nov 6, 2026 | $253.47 |
| Nov 9, 2026 | $259.44 |
| Nov 10, 2026 | $257.23 |
| Nov 11, 2026 | $257.79 |
| Nov 12, 2026 | $254.46 |
| Nov 13, 2026 | $252.73 |
| Nov 16, 2026 | $248.82 |
Daily net flows, 1M
Net inflow over the range: +$25M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Oct 13 | $0 |
| Oct 14 | $0 |
| Oct 15 | $0 |
| Oct 16 | $0 |
| Oct 19 | $2.4M |
| Oct 20 | $0 |
| Oct 21 | $0 |
| Oct 22 | $2.5M |
| Oct 23 | $0 |
| Oct 26 | $0 |
| Oct 27 | $0 |
| Oct 28 | $0 |
| Oct 29 | $0 |
| Oct 30 | $0 |
| Nov 2 | $2.6M |
| Nov 3 | $2.6M |
| Nov 4 | $0 |
| Nov 5 | $2.6M |
| Nov 6 | $0 |
| Nov 9 | $0 |
| Nov 10 | $5.2M |
| Nov 11 | $0 |
| Nov 12 | $0 |
| Nov 13 | $7.6M |
Money keeps arriving — +$25M of net inflows over the past month, about 4.7% of the fund's asset base, while the price has returned +31.5% so far this year. At 0.35% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | AMGNAMGEN | 16.85% | $462.32 | -0.7% | ||
| 2 | GILDGILEAD SCIENCES | 14.37% | $167.58 | -0.3% | ||
| 3 | VRTXVERTEX PHARMACEUTICALS | 8.18% | $537.79 | -0.2% | ||
| 4 | REGNREGENERON PHARMACEUTICALS | 7.92% | $952.40 | -0.3% | ||
| 5 | MRNAMODERNA | 6.80% | $215.27 | -3.6% | ||
| 6 | ARGXARGENX SE | 4.44% | $950.95 | -0.9% | ||
| 7 | IQVIQVIA HOLDINGS | 4.26% | $264.73 | -0.1% | ||
| 8 | NTRANATERA | 3.69% | $288.48 | -9.6% | ||
| 9 | RVMDREVOLUTION MEDICINES | 3.42% | $166.87 | -3.1% | ||
| 10 | ONCBeiGene | 3.04% | $411.29 | -1.3% | ||
| 11 | BIIBBIOGEN | 2.96% | $251.65 | -0.7% | ||
| 12 | ILMNILLUMINA | 2.96% | $198.00 | -4.4% | ||
| 13 | UTHRUNITED THERAPEUTICS | 2.36% | $587.88 | -0.6% | ||
| 14 | GHGUARDANT HEALTH | 2.47% | $144.03 | -5.1% | ||
| 15 | INSMINSMED | 2.17% | $122.88 | +1.4% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 25Sector weights
- Healthcare100%
- Health Technology86.57%
- Commercial Services7.67%
- Health Services5.76%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 86.57% |
| Commercial Services | 7.67% |
| Health Services | 5.76% |
Country weights
- United States100%
- Ireland4.43%
- China3.87%
- Netherlands2.82%
- Germany1.95%
- Spain1.67%
- Hong Kong1.62%
- Switzerland0.81%
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 4.43% |
| China | 3.87% |
| Netherlands | 2.82% |
| Germany | 1.95% |
| Spain | 1.67% |
| Hong Kong | 1.62% |
| Switzerland | 0.81% |
| 1 week | -3.3% |
| 1 month | +3.1% |
| 3 months | +14.1% |
| 6 months | +36.9% |
| YTD | +31.5% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$13M |
| 1 month | +$25M |
| 3 months | +$42M |
| YTD | +$35M |
| 1 year | +$39M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Dec | −$324.7K |
| Jan | $94.6K |
| Feb | −$2M |
| Mar | $145.6K |
| Apr | −$1.9M |
| May | −$3.7M |
| Jun | $12K |
| Jul | $0 |
| Aug | $9.6M |
| Sep | $2.6M |
| Oct | $9.6M |
| Nov | $20.5M |
The top holding is 16.9% of the book; the top ten carry 73%. Spread across 27+ names, it behaves like roughly 13 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| MRNA MODERNA | $30M | $26M |
| NTRA NATERA | $20M | $1M |
| TEM TEMPUS AI INC | $3M | $5M |
| REGN REGENERON PHARMACEUTICALS | $4M | $2M |
| AMGN AMGEN | $3M | $3M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat BBH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -32bp on fee · 78× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -32bp on fee · 34× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -30bp on fee · 231× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -31bp on fee · 64× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -31bp on fee · 44× the assets · +$422M in over the month | Head-to-head |


